Sprague John M
- SEC CIK
- 0001730056
No open-market purchases or sales filed in the past year.
Current role at each company
- TTOO T2 Biosystems, Inc.CFOas of Jan 2, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sprague John M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2023 (view filing) | Feb 22-28 | 15 daysLate | Sprague John MChief Financial Officer | SSale | −2.69K | $0.6244 | −$1.68K | −27.0%7.27K after | 2 lots |
| Apr 11, 2022 (view filing)9:40 AM ET | Apr 8 | 3 days | Sprague John MChief Financial Officer | PPurchase | +10.0K | $0.4767 | +$4.77K | +7.0%152.3K after |